Agrafiotis, A.C.; Berzenji, L.; Koyen, S.; Vermeulen, D.; Winthagen, R.; Hendriks, J.M.H.; Van Schil, P.E.
An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors. Int. J. Mol. Sci. 2023, 24, 17065.
https://doi.org/10.3390/ijms242317065
AMA Style
Agrafiotis AC, Berzenji L, Koyen S, Vermeulen D, Winthagen R, Hendriks JMH, Van Schil PE.
An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors. International Journal of Molecular Sciences. 2023; 24(23):17065.
https://doi.org/10.3390/ijms242317065
Chicago/Turabian Style
Agrafiotis, Apostolos C., Lawek Berzenji, Stien Koyen, Dries Vermeulen, Rachel Winthagen, Jeroen M. H. Hendriks, and Paul E. Van Schil.
2023. "An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors" International Journal of Molecular Sciences 24, no. 23: 17065.
https://doi.org/10.3390/ijms242317065
APA Style
Agrafiotis, A. C., Berzenji, L., Koyen, S., Vermeulen, D., Winthagen, R., Hendriks, J. M. H., & Van Schil, P. E.
(2023). An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors. International Journal of Molecular Sciences, 24(23), 17065.
https://doi.org/10.3390/ijms242317065
